AgeX Therapeutics, Inc.

AMEX:AGE

0.4302 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Operating Activities:
Net Income -9.437-3.456-5.389-2.679-3.285-2.761-2.436-2.618-2.707-2.159-1.955-2.475-1.993-2.458-2.565-2.731-3.222-2.741-3.277-3.155-3.211-3.274-2.185-1.951-0.321
Depreciation & Amortization 0.0250.0330.0330.0320.0330.0330.0330.0330.0330.0330.0320.0330.0330.5770.370.3680.3670.2940.2570.2510.1490.150.1460.1170.122
Deferred Income Tax 0-0.734-0.175-0.1990000000-0.437-0.1960.0610.0140.0390.005-0.0730.0560.0660.0730.0880.0340.021-3.215
Stock Based Compensation 0.0530.5030.040.0350.070.1140.2090.1980.2390.2630.2720.2860.1780.1820.2320.2590.260.420.4910.5150.4810.7970.210.2310.235
Change In Working Capital 00.4680.433-0.1270.230.3720.127-0.3380.168-0.078-0.5160.192-0.482-0.192-0.087-0.2620.479-0.4120.181-0.04-0.1390.3020.042-0.5070.374
Accounts Receivables 0-0.165-0.236-0.203-0.003-0.0170.0110.0130.0250.128000.1050.010.0940-0.028-0.23200-0.075-0.024000
Change In Inventory 0-0.5790.2360.20300-0.011000001.546-0.633-0.1490-0.002-0.12800-0.056-0.125000
Change In Accounts Payables 0.6440.5790.667-0.3010.2050.2420.109-0.4140.207-0.153-0.3770.104-0.3460.1030.051-0.3080.494-0.150.1980.173-0.0520.4070.091-0.1320.282
Other Working Capital 00.633-0.2340.174-0.2020.1470.0180.063-0.064-0.053-0.1390.088-1.7870.328-0.0830.0460.0150.098-0.017-0.2130.0440.044-0.049-0.3750.092
Other Non Cash Items 01.1343.1940.9191.0870.9210.8310.9790.6310.2940.2830.707-0.170.210.1470.0830.0470.101-0.08-0.3960.029-0.109-0.03-0.0720.8
Operating Cash Flow -1.577-2.052-1.864-2.019-1.865-1.321-1.236-1.746-1.636-1.647-1.884-1.694-2.63-1.62-1.889-2.244-2.064-2.411-2.372-2.759-2.618-2.046-1.783-2.161-2.005
Investing Activities:
Investments In Property Plant And Equipment 00000000000000.02-0.012-0.004-0.004-0.295-0.237-0.106-0.0031.893-1.08-0.012-0.801
Acquisitions Net 000000000-0.466000.4660000-0.3540.0770.2770-3.215003.215
Purchases Of Investments 0000000000000000000000000
Sales Maturities Of Investments 0000000000000000000000000
Other Investing Activites -0.014000-1000000.71600-0.0500000.3540.003-0.07701.3250.00200
Investing Cash Flow -0.014000-1000000.25000.4160.02-0.012-0.004-0.004-0.295-0.1570.094-0.0030.003-1.078-0.0122.414
Financing Activities:
Debt Repayment -0.01322211.5-1.5-1-200000-0.142-0.1490-0.015-0.013-0.013000000
Common Stock Issued 36.40400000.0080000000.4960.0210000.0560000000
Common Stock Repurchased 0000000000000000000000000
Dividends Paid 0000000000000000000000000
Other Financing Activities -33.66300002.992121.51.2521.521.1132.1262.8070.21.2440.5-0.0094.500.26350.737
Financing Cash Flow 2.72822211.51.5121.51.2521.52.4960.9921.9772.8070.1851.2870.487-0.0094.500.26350.737
Other Information:
Effect Of Forex Changes On Cash 0000000000.3000-0.002-0.0020.006-0.0010.003-0.0030.0010-0.006-0.0010.008-0.001
Net Change In Cash 1.137-0.0520.136-0.019-0.3650.179-0.2360.254-0.136-0.1470.116-0.1940.282-0.630.0740.565-1.884-1.416-2.045-2.6731.879-2.049-2.5992.8351.145
Cash At End Of Period 8.7560.3450.4470.3110.330.6950.5160.7520.4980.6340.7810.6650.8590.5771.2071.1330.5682.4523.8685.9138.5866.7078.75611.3558.52